Clinical Presentation, Etiology and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis-Prospective Cohort Study
By D. Murdoch, G. Corey, B. Hoen, J. Miró, V. Fowler, A. Bayer, A. Karchmer, L. Olaison, P. Pappas, P. Moreillon and 13 more. Archives of Internal Medicine, 2009
2,265 citations recorded by the source corpus.
Background The aim of this study was to provide a contemporary picture of the presentation, etiology and outcome of infective endocarditis (IE) in a large patient cohort from multiple locations worldwide. Methods Prospective cohort study of 2781 adults with definite IE admitted to 58 hospitals in 25 countries between June 2000 and September 2005. Results The median age of the cohort was 57.9 (IQR 43.2–71.8) years and 72% had native valve IE. Most (77%) patients presented early in the disease (<30 days) with few of the classic clinical hallmarks of IE. Recent health-care exposure was found in one quarter of patients. Staphylococcus aureus was the most common pathogen (31%). Mitral (41%) and aortic (38%) valves were infected most commonly. Complications were common: stroke (17%); embolization other than stroke (23%); heart failure (32%) and intracardiac abscess (14%). Surgical therapy was common (48%) and in-hospital mortality remained high (18%). Prosthetic valve involvement (OR 1.47, 95%CI 1.13–1.90), increasing age (OR 1.30, 95%CI 1.17–1.46 per 10-year interval), pulmonary edema (OR 1.79, 95%CI 1.39–2.30), S. aureus infection (OR 1.54, 95%CI 1.14–2.08), coagulase-negative staphylococcal infection (OR 1.50, 95%CI 1.07–2.10), mitral valve vegetation (OR 1.34, 95%CI 1.06–1.68), and paravalvular complications (OR 2.25, 95%CI 1.64–3.09) were associated with increased risk of in-hospital death, while viridans streptococcal infection (OR 0.52, 95%CI 0.33–0.81) and surgery (OR 0.61, 95%CI 0.44–0.83) were associated with decreased risk. Conclusions In the early 21st century, IE is more often an acute disease, characterized by a high rate of S. aureus infection. Mortality remains relatively high.
Subfields: Clinical Biochemistry, Epidemiology, Parasitology
View Paper: https://www.semanticscholar.org/paper/2b765db937fa5a9d11b7c1fac408df558152eea3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
Citations in the corpus
- Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. (2012, background): “pathogens in cases of IE [9]; these findings were later confirmed by different observational studies [1, 6].”
- GUIDELINES ON THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFECTIVE ENDOCARDITIS (NEW VERSION 2009) (2010, neutral): “Causative microorganisms are most often staphylococci, streptococci, and enterococci.(28)”
- Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. (2019, background): “Although MSCT was used in more than half of patients in EUROENDO, cardiac CT was performed in only 10%, demonstrating clear underuse of this technique, particularly for the diagnosis of perivalvular involvement in PVIE.8,11 Management and outcome of infective endocarditis in EUROENDO registry Use of”